198 related articles for article (PubMed ID: 29574092)
1. Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging.
Chen X; Zhou H; Li X; Duan N; Hu S; Liu Y; Yue Y; Song L; Zhang Y; Li D; Wang Z
EBioMedicine; 2018 Apr; 30():129-137. PubMed ID: 29574092
[TBL] [Abstract][Full Text] [Related]
2. A novel plectin/integrin-targeted bispecific molecular probe for magnetic resonance/near-infrared imaging of pancreatic cancer.
Wang Q; Yan H; Jin Y; Wang Z; Huang W; Qiu J; Kang F; Wang K; Zhao X; Tian J
Biomaterials; 2018 Nov; 183():173-184. PubMed ID: 30172243
[TBL] [Abstract][Full Text] [Related]
3. Optical magnetic multimodality imaging of plectin-1-targeted imaging agent for the precise detection of orthotopic pancreatic ductal adenocarcinoma in mice.
Zhang W; Liang X; Zhu L; Zhang X; Jin Z; Du Y; Tian J; Xue H
EBioMedicine; 2022 Jun; 80():104040. PubMed ID: 35525203
[TBL] [Abstract][Full Text] [Related]
4. Emodin-Conjugated PEGylation of Fe
Ren S; Song L; Tian Y; Zhu L; Guo K; Zhang H; Wang Z
Int J Nanomedicine; 2021; 16():7463-7478. PubMed ID: 34785894
[TBL] [Abstract][Full Text] [Related]
5. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
[TBL] [Abstract][Full Text] [Related]
6. Development and
Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
[TBL] [Abstract][Full Text] [Related]
7. Integrin α
Li D; Dong C; Ma X; Zhao X
Cancer Imaging; 2021 Jun; 21(1):44. PubMed ID: 34187570
[TBL] [Abstract][Full Text] [Related]
8. Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma.
Kelly KA; Bardeesy N; Anbazhagan R; Gurumurthy S; Berger J; Alencar H; Depinho RA; Mahmood U; Weissleder R
PLoS Med; 2008 Apr; 5(4):e85. PubMed ID: 18416599
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.
Yang L; Mao H; Cao Z; Wang YA; Peng X; Wang X; Sajja HK; Wang L; Duan H; Ni C; Staley CA; Wood WC; Gao X; Nie S
Gastroenterology; 2009 May; 136(5):1514-25.e2. PubMed ID: 19208341
[TBL] [Abstract][Full Text] [Related]
10. Facile assembly of upconversion nanoparticle-based micelles for active targeted dual-mode imaging in pancreatic cancer.
Han Y; An Y; Jia G; Wang X; He C; Ding Y; Tang Q
J Nanobiotechnology; 2018 Jan; 16(1):7. PubMed ID: 29378593
[TBL] [Abstract][Full Text] [Related]
11. Survivin-targeted nanoparticles for pancreatic tumor imaging in mouse model.
Wang Z; Tong M; Chen X; Hu S; Yang Z; Zhang Y; Zhou H; Wu Y; Li X; Li D
Nanomedicine; 2016 Aug; 12(6):1651-61. PubMed ID: 26995092
[TBL] [Abstract][Full Text] [Related]
12. PSA targeted dual-modality manganese oxide-mesoporous silica nanoparticles for prostate cancer imaging.
Du D; Fu HJ; Ren WW; Li XL; Guo LH
Biomed Pharmacother; 2020 Jan; 121():109614. PubMed ID: 31731188
[TBL] [Abstract][Full Text] [Related]
13. LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer.
Abulrob A; Corluka S; Blasiak B; Gino Fallone B; Ponjevic D; Matyas J; Tomanek B
Mol Imaging Biol; 2018 Jun; 20(3):428-435. PubMed ID: 29101636
[TBL] [Abstract][Full Text] [Related]
14. The role of exendin-4-conjugated superparamagnetic iron oxide nanoparticles in beta-cell-targeted MRI.
Zhang B; Yang B; Zhai C; Jiang B; Wu Y
Biomaterials; 2013 Jul; 34(23):5843-52. PubMed ID: 23642536
[TBL] [Abstract][Full Text] [Related]
15. Bombesin-functionalized superparamagnetic iron oxide nanoparticles for dual-modality MR/NIRFI in mouse models of breast cancer.
Li L; Wu C; Pan L; Li X; Kuang A; Cai H; Tian R
Int J Nanomedicine; 2019; 14():6721-6732. PubMed ID: 31686805
[TBL] [Abstract][Full Text] [Related]
16. Anti-CXCR4 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles in an application of MR molecular imaging of pancreatic cancer cell lines.
He Y; Song W; Lei J; Li Z; Cao J; Huang S; Meng J; Xu H; Jin Z; Xue H
Acta Radiol; 2012 Nov; 53(9):1049-58. PubMed ID: 23012484
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody.
Liu F; Le W; Mei T; Wang T; Chen L; Lei Y; Cui S; Chen B; Cui Z; Shao C
Int J Nanomedicine; 2016; 11():2195-207. PubMed ID: 27274243
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
[TBL] [Abstract][Full Text] [Related]
19. Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo.
Lee H; Yu MK; Park S; Moon S; Min JJ; Jeong YY; Kang HW; Jon S
J Am Chem Soc; 2007 Oct; 129(42):12739-45. PubMed ID: 17892287
[TBL] [Abstract][Full Text] [Related]
20. In vivo magnetic resonance imaging of pancreatic tumors using iron oxide nanoworms targeted with PTR86 peptide.
Ahmadi Y; Kostenich G; Oron-Herman M; Wadsak W; Mitterhauser M; Orenstein A; Mirzaei S; Knoll P
Colloids Surf B Biointerfaces; 2017 Oct; 158():423-430. PubMed ID: 28719864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
